Abstract
We report the use of engineered ribozymes to shuffle exon cassettes in vitro. Specifically, we have designed derivatives of a group II intron that insert into selected sites in the human tissue plasminogen activator (t-PA) mRNA. The insertion reaction links t-PA sequences to the group II intron sequences so that trans-splicing reactions catalyzed by the intron can be employed to shuffle the t-PA sequences. We expect these results to be generalizable, so that similar ribozymes can be designed to target any desired 13 nucleotide sequence. In principle, the reactions we describe here should be able to link any RNA molecule to any other RNA molecule at any selected point.
MeSH Terms
Base Sequence
DNA Primers
Epidermal Growth Factor/biosynthesis
Exons
Fibronectins/biosynthesis
Genetic Engineering/methods
Humans
Introns
Molecular Sequence Data
Polymerase Chain Reaction
RNA Splicing
RNA, Catalytic/biosynthesis,metabolism
RNA, Messenger/biosynthesis
Recombinant Fusion Proteins/biosynthesis
Restriction Mapping
Tissue Plasminogen Activator/biosynthesis
Transcription, Genetic
Chemicals
DNA Primers
Fibronectins
RNA, Catalytic
RNA, Messenger
Recombinant Fusion Proteins
Epidermal Growth Factor
Tissue Plasminogen Activator
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Mikheeva S
Department of Pharmacology and Experimental Therapeutics, Boston University Medical Center, MA 02118, USA.
Jarrell K A
References (19)
19 references, click to expand
-
Reverse self-splicing of group II intron RNAs in vitro.
Nature. 1990 Jan 25;343(6256):383-6
PMID: 1689013
-
Group II intron domain 5 facilitates a trans-splicing reaction.
Mol Cell Biol. 1988 Jun;8(6):2361-6
PMID: 3405208
-
Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis.
Annu Rev Pharmacol Toxicol. 1990;30:91-121
PMID: 2111656
-
Splice site selection and role of the lariat in a group II intron.
J Mol Biol. 1991 Jun 5;219(3):415-28
PMID: 1711123
-
Structural requirements for selection of 5'- and 3' splice sites of group II introns.
Nucleic Acids Res. 1991 Jun 25;19(12):3307-14
PMID: 2062646
-
Group II introns deleted for multiple substructures retain self-splicing activity.
Mol Cell Biol. 1992 May;12(5):1950-8
PMID: 1569932
-
Inverse splicing of a group II intron.
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8624-7
PMID: 8378340
-
The multiplicity of domains in proteins.
Annu Rev Biochem. 1995;64:287-314
PMID: 7574483
-
Structure and activities of group II introns.
Annu Rev Biochem. 1995;64:435-61
PMID: 7574489
-
Why genes in pieces?
Nature. 1978 Feb 9;271(5645):501
PMID: 622185
-
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.
Nature. 1983 Jan 20;301(5897):214-21
PMID: 6337343
-
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.
Proc Natl Acad Sci U S A. 1984 Sep;81(17):5355-9
PMID: 6089198
-
Genes-in-pieces revisited.
Science. 1985 May 17;228(4701):823-4
PMID: 4001923
-
A self-splicing RNA excises an intron lariat.
Cell. 1986 Jan 31;44(2):213-23
PMID: 3510741
-
Excised group II introns in yeast mitochondria are lariats and can be formed by self-splicing in vitro.
Cell. 1986 Jan 31;44(2):225-34
PMID: 2417726
-
Multiple exon-binding sites in class II self-splicing introns.
Cell. 1987 Jul 3;50(1):17-29
PMID: 3297351
-
Group II intron self-splicing. Alternative reaction conditions yield novel products.
J Biol Chem. 1988 Mar 5;263(7):3432-9
PMID: 2830285
-
Group II intron self-splicing: development of alternative reaction conditions and identification of a predicted intermediate.
Cold Spring Harb Symp Quant Biol. 1987;52:223-32
PMID: 3331340
-
Integration of group II intron bI1 into a foreign RNA by reversal of the self-splicing reaction in vitro.
Cell. 1990 Feb 23;60(4):629-36
PMID: 2406027